Indeed, preclinical evidences in murine models of mesothelioma showed that chemotherapy in combination with immunotherapy increased the tumoral CD4+/CD8+ immune infiltrate and induced long term tumoral responses (70, 71). Here, CD4 is linked to mesothelioma.